Join our daily newsletter At The Bell to receive exclusive market insights
- Microba Life Sciences (MAP) signs a strategic partnership agreement with healthcare company, Midnight Health, to deliver personalised health service to the Australian market
- The agreement will see the companies collaborate on a new subscription based service, known as Vidality
- The service aims to leverage its network of pharmacists to formulate personalised supplements based on customers microbiome test results
- Shares are trading two per cent lower today at 24.5 cents each at market close
Microba Life Sciences (MAP) has signed a strategic partnership agreement with healthcare company, Midnight Health, to deliver personalised health services to the Australian market.
The agreement will see the companies collaborate to promote, market, and sell a new subscription based service, known as Vidality.
The service aims to leverage its network of pharmacists to formulate personalised supplements based on customers microbiome test results.
Chief Executive Officer Dr Luke Reid is pleased with the agreement.
“Consumers are seeking personalised, evidence-based solutions to support their gut health,” he said.
“Together with Midnight Health, we are excited to bring the Vidality product to consumers, a truly personalised solution powered by our technology.”
Shares were trading two per cent lower today at 24.5 cents each at market close.
